New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
NFH.WS
NFH.WS was delisted on the 26th of January, 2022.
16 hedge funds and large institutions have $7.89M invested in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
7% more funds holding
Funds holding: 15 → 16 (+1)
16% less capital invested
Capital invested by funds: $9.39M → $7.89M (-$1.49M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Segantii Capital Management
Hong Kong
|
+$335K |
| 2 |
MTCM
Mint Tower Capital Management
Amsterdam,
Netherlands
|
+$161K |
| 3 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$123K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$516 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.97M |
| 2 |
AGC
Angelo Gordon & Co
New York
|
-$1.66M |
| 3 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$1.01M |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$38.9K |
| 5 |
GCL
Glazer Capital LLC
New York
|
-$20.3K |
NFH.WS Hedge Fund Activity: Q3 2020 in Review
16 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) for Q3 2020, worth a combined $7.89M — down 16% from $9.39M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NFH.WS positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Segantii Capital Management, opening a new position worth an estimated $335K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $1.97M sold.
- 16 institutional investors held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) as of Q3 2020, up from 15 in Q2 2020.
- Funds reported $7.89M of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a stock for Q3 2020, down 16% quarter-over-quarter.
- 3 funds opened new New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a positions in Q3 2020 and 2 closed out, a net change of +1 holder.
- The largest New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a buyer in Q3 2020 was Segantii Capital Management, an estimated $335K added.
- The largest New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a seller in Q3 2020 was Alyeska Investment Group, an estimated $1.97M sold.
Based on aggregated 13F filings for Q3 2020.